Published in PLoS One on September 27, 2011
Mesenchymal Stem Cell Therapy for Liver Cirrhosis | NCT03626090
IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J Clin Invest (2012) 2.64
Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer. Nature (2014) 1.88
Cell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cells. Anesthesiology (2014) 0.94
Candida albicans colonization and dissemination from the murine gastrointestinal tract: the influence of morphology and Th17 immunity. Cell Microbiol (2014) 0.86
Amniotic-fluid-derived mesenchymal stem cells overexpressing interleukin-1 receptor antagonist improve fulminant hepatic failure. PLoS One (2012) 0.84
IL-1 Receptor Antagonist Treatment Aggravates Staphylococcal Septic Arthritis and Sepsis in Mice. PLoS One (2015) 0.79
Stimulation of Proliferation and Migration of Mouse Macrophages by Type B CpG-ODNs Is F-Spondin and IL-1Ra Dependent. PLoS One (2015) 0.77
Monocyte chemoattractant protein-1 is not required for liver regeneration after partial hepatectomy. J Inflamm (Lond) (2016) 0.75
The Role of IL-1 Family Members and Kupffer Cells in Liver Regeneration. Biomed Res Int (2016) 0.75
Proteomic analysis of immediate-early response plasma proteins after 70% and 90% partial hepatectomy. Hepatol Res (2012) 0.75
Sustained Inhibition of Proliferative Response After Transient FGF Stimulation Is Mediated by Interleukin 1 Signaling. J Cell Physiol (2016) 0.75
Interleukin-1 receptor antagonist expression is inversely associated with outcomes of hepatitis B-related acute-on-chronic liver failure. Exp Ther Med (2017) 0.75
Liver regeneration: from myth to mechanism. Nat Rev Mol Cell Biol (2004) 6.36
Elimination of primer-dimer artifacts and genomic coamplification using a two-step SYBR green I real-time RT-PCR. Anal Biochem (2002) 4.54
A reproducible and well-tolerated method for 2/3 partial hepatectomy in mice. Nat Protoc (2008) 4.02
Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol (1998) 3.78
Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation. N Engl J Med (1998) 3.77
The balance between IL-1 and IL-1Ra in disease. Cytokine Growth Factor Rev (2002) 3.69
Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist. J Clin Invest (1990) 2.83
CCAAT enhancer- binding protein beta is required for normal hepatocyte proliferation in mice after partial hepatectomy. J Clin Invest (1998) 2.74
The precursor form of IL-1alpha is an intracrine proinflammatory activator of transcription. Proc Natl Acad Sci U S A (2004) 2.61
Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein. J Clin Invest (1997) 2.56
Liver regeneration 4: transcriptional control of liver regeneration. FASEB J (1996) 2.31
Anakinra, a recombinant human interleukin-1 receptor antagonist, inhibits apoptosis in experimental acute myocardial infarction. Circulation (2008) 2.23
Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proc Natl Acad Sci U S A (1996) 2.18
Alveolar macrophage-derived cytokines induce monocyte chemoattractant protein-1 expression from human pulmonary type II-like epithelial cells. J Biol Chem (1991) 2.06
Reg2 inactivation increases sensitivity to Fas hepatotoxicity and delays liver regeneration post-hepatectomy in mice. Hepatology (2006) 1.61
Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines. J Clin Invest (1993) 1.54
Hepatocyte transplantation. J Hepatol (2004) 1.50
Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair. Hepatology (2006) 1.49
Concern Low concentration of interleukin-1beta induces FLICE-inhibitory protein-mediated beta-cell proliferation in human pancreatic islets. Diabetes (2006) 1.47
Is IL-1 a good therapeutic target in the treatment of arthritis? Best Pract Res Clin Rheumatol (2006) 1.46
Acute hepatic failure: a Western perspective. J Gastroenterol Hepatol (2000) 1.32
An inducible autocrine cascade regulates rat hepatocyte proliferation and apoptosis responses to tumor necrosis factor-alpha. Hepatology (2008) 1.30
Cyclin D1 promotes mitogen-independent cell cycle progression in hepatocytes. Cell Growth Differ (1999) 1.29
Transcriptional activation of the p21(WAF1,CIP1,SDI1) gene by interleukin-6 type cytokines. A prerequisite for their pro-differentiating and anti-apoptotic effects on human osteoblastic cells. J Biol Chem (1998) 1.26
Circulating proinflammatory cytokines (IL-1 beta, TNF-alpha, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis. Clin Exp Immunol (1994) 1.25
Hyperstimulation with interleukin 6 inhibits cell cycle progression after hepatectomy in mice. Hepatology (2000) 1.24
Monocyte chemoattractant protein-1 (MCP-1) expression in human articular cartilage. Induction by peptide regulatory factors and differential effects of dexamethasone and retinoic acid. J Clin Invest (1992) 1.20
Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protein-2 and Kupffer cells. Hepatology (1998) 1.17
Interleukin 1 receptor blockade reduces tumor necrosis factor production, tissue injury, and mortality after hepatic ischemia-reperfusion in the rat. Transplantation (1997) 1.15
Comparison between effects of interleukin-1 alpha administration and sublethal endotoxemia in primates. Am J Physiol (1991) 1.12
Early up-regulation of chemokine expression in fulminant hepatic failure. J Pathol (2003) 1.11
A bioartificial liver device secreting interleukin-1 receptor antagonist for the treatment of hepatic failure in rats. J Surg Res (2006) 1.08
Secretion of intracellular IL-1 receptor antagonist (type 1) is dependent on P2X7 receptor activation. J Immunol (2004) 1.08
Serum hepatocyte growth factor levels in liver diseases: clinical implications. Hepatology (1995) 1.08
Nonparenchymal cells from regenerating rat liver generate interleukin-1alpha and -1beta: a mechanism of negative regulation of hepatocyte proliferation. Hepatology (1997) 1.06
Liver regeneration: methods for monitoring and their applications. J Hepatol (1997) 1.05
Activated platelets trigger an inflammatory response and enhance migration of aortic smooth muscle cells. Thromb Res (2003) 1.03
Prometheus' challenge: molecular, cellular and systemic aspects of liver regeneration. J Surg Res (2006) 1.02
The role of cytokines in liver failure and regeneration: potential new molecular therapies. Biochim Biophys Acta (2002) 1.00
Adenoviral overexpression of interleukin-1 receptor antagonist protein increases beta-cell replication in rat pancreatic islets. Gene Ther (2005) 0.98
Treatment of fulminant hepatic failure in rats using a bioartificial liver device containing porcine hepatocytes producing interleukin-1 receptor antagonist. Tissue Eng (2006) 0.97
Production of IL-1 receptor antagonist by hepatocytes is regulated as an acute-phase protein in vivo. Eur J Immunol (2001) 0.96
The inhibitory effect of interleukin 1beta on rat hepatocyte DNA synthesis is mediated by nitric oxide. Hepatology (1998) 0.94
Granulocyte colony-stimulating factor impairs liver regeneration in mice through the up-regulation of interleukin-1beta. J Hepatol (2007) 0.91
Transfer of the interleukin-1 receptor antagonist gene into rat liver abrogates hepatic ischemia-reperfusion injury. Transplantation (2002) 0.90
Imbalance of IL-1 beta and IL-1 receptor antagonist mRNA in liver tissue from hepatitis C virus (HCV)-related chronic hepatitis. Clin Exp Immunol (1999) 0.89
IL-1 receptor antagonist inhibits monocyte chemotactic peptide 1 generation by human mesangial cells. Kidney Int (1992) 0.88
Expression of hepatocyte growth factor, transforming growth factor alpha, and transforming growth factor beta 1 messenger RNA in various human liver diseases and correlation with hepatocyte proliferation. Hepatology (1996) 0.84
Octreotide regulates CC but not CXC LPS-induced chemokine secretion in rat Kupffer cells. Br J Pharmacol (2004) 0.83
Anti-inflammatory effects of hepatocyte growth factor: induction of interleukin-1 receptor antagonist. Eur Cytokine Netw (2005) 0.83
ICU management of acute liver failure. Clin Chest Med (2009) 0.83
Regulation of monocyte chemoattractant protein 1 by cytokines and oxygen free radicals in rat hepatic fat-storing cells. Gastroenterology (1996) 0.82
Endotoxin and interleukin-1 related hepatic inflammatory response promotes liver failure after partial hepatectomy. Hepatology (1995) 0.82
Interleukin-1 receptor antagonist (IL-1ra) modulates endothelial cell proliferation. FEBS Lett (2008) 0.82
International trial of the Edmonton protocol for islet transplantation. N Engl J Med (2006) 13.43
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol (2008) 5.93
Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg (2005) 4.86
Budd-Chiari syndrome: a review by an expert panel. J Hepatol (2003) 3.69
Single port access laparoscopic cholecystectomy (with video). World J Surg (2009) 3.29
Rates and patterns of recurrence following curative intent surgery for colorectal liver metastasis: an international multi-institutional analysis of 1669 patients. Ann Surg (2009) 3.15
Single port access laparoscopic right hemicolectomy. Int J Colorectal Dis (2008) 3.08
Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Ann Surg (2006) 2.70
Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis. Hepatology (2006) 2.38
A prospective, randomized, single-blind comparison of laparoscopic versus open sigmoid colectomy for diverticulitis. Ann Surg (2010) 2.34
Mechanical bowel preparation for elective colorectal surgery: a meta-analysis. Arch Surg (2004) 2.32
Management of gastrointestinal stromal tumors: from diagnosis to treatment. Swiss Med Wkly (2004) 2.29
Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol (2011) 2.13
The impact of waiting list alpha-fetoprotein changes on the outcome of liver transplant for hepatocellular carcinoma. J Hepatol (2011) 2.12
Two colons-two cancers: paradigm shift and clinical implications. J Surg Oncol (2004) 2.09
Unique arrangement of alpha- and beta-cells in human islets of Langerhans. Diabetes (2010) 2.09
Single-port access laparoscopic radical left colectomy in humans. Dis Colon Rectum (2009) 2.04
Intussusception as a cause of bowel obstruction in adults. Swiss Med Wkly (2005) 1.99
Early prediction of acute pancreatitis: prospective study comparing computed tomography scans, Ranson, Glascow, Acute Physiology and Chronic Health Evaluation II scores, and various serum markers. World J Surg (2002) 1.87
Incidence, consequences, and risk factors for anastomotic dehiscence after colorectal surgery: a prospective monocentric study. Int J Colorectal Dis (2007) 1.81
Surgical management of abdominal and retroperitoneal Castleman's disease. World J Surg Oncol (2005) 1.74
Polyfunctional HCV-specific T-cell responses are associated with effective control of HCV replication. Eur J Immunol (2008) 1.70
A survival analysis of the liver-first reversed management of advanced simultaneous colorectal liver metastases: a LiverMetSurvey-based study. Ann Surg (2012) 1.69
Glucose-stimulated insulin secretion is coupled to the interaction of actin with the t-SNARE (target membrane soluble N-ethylmaleimide-sensitive factor attachment protein receptor protein) complex. Mol Endocrinol (2003) 1.65
Improved long-term outcome of surgery for advanced colorectal liver metastases: reasons and implications for management on the basis of a severity score. Ann Surg Oncol (2007) 1.60
Complications of elective liver resections in a center with low mortality: a simple score to predict morbidity. Arch Surg (2011) 1.57
Value of contrast-enhanced 18F-fluorodeoxyglucose positron emission tomography/computed tomography in detection and presurgical assessment of pancreatic cancer: a prospective study. J Gastroenterol Hepatol (2011) 1.57
Potential impact of in situ liver splitting on the number of available grafts. Transplantation (2002) 1.55
OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. J Clin Oncol (2005) 1.52
Expectations and strategies regarding islet transplantation: metabolic data from the GRAGIL 2 trial. Transplantation (2007) 1.50
Infection and rejection in liver transplant patients: a 10-year Swiss single-centre experience. Swiss Med Wkly (2005) 1.48
Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis. Histopathology (2010) 1.48
Low risk of anti-human leukocyte antigen antibody sensitization after combined kidney and islet transplantation. Transplantation (2008) 1.47
Highly efficient lentiviral vector-mediated transduction of nondividing, fully reimplantable primary hepatocytes. Mol Ther (2002) 1.46
Repeat curative intent liver surgery is safe and effective for recurrent colorectal liver metastasis: results from an international multi-institutional analysis. J Gastrointest Surg (2009) 1.41
Notice of duplicate publication: "Mechanical bowel preparation for elective colorectal surgery: a meta-analysis" (Arch Surg. 2004;139:1359-1364). Arch Surg (2006) 1.41
Assessment of a novel two-component enzyme preparation for human islet isolation and transplantation. Transplantation (2005) 1.40
The role of hepatic ischemia-reperfusion injury and liver parenchymal quality on cancer recurrence. Dig Dis Sci (2014) 1.39
Preoperative concomitant hyperfractionated radiotherapy and gemcitabine for locally advanced rectal cancers: a phase I-II trial. Cancer J (2005) 1.38
Risk factors for early and late biliary complications in pediatric liver transplantation. Pediatr Transplant (2014) 1.38
Conditional survival after surgical resection of colorectal liver metastasis: an international multi-institutional analysis of 949 patients. J Am Coll Surg (2010) 1.37
Current situation of donation after circulatory death in European countries. Transpl Int (2011) 1.32
Surgery versus intra-arterial therapy for neuroendocrine liver metastasis: a multicenter international analysis. Ann Surg Oncol (2011) 1.31
Low- and high-density lipoproteins modulate function, apoptosis, and proliferation of primary human and murine pancreatic beta-cells. Endocrinology (2009) 1.29
Population perception of surgical safety and body image trauma: a plea for scarless surgery? Surg Endosc (2010) 1.24
Comparison between hepatic wedge resection and anatomic resection for colorectal liver metastases. J Gastrointest Surg (2006) 1.22
A simple score for predicting alcohol relapse after liver transplantation: results from 387 patients over 15 years. Arch Intern Med (2007) 1.21
Morphologic alterations associated with mechanical bowel preparation before elective colorectal surgery: a randomized trial. Dis Colon Rectum (2006) 1.20
Augmented reality and image overlay navigation with OsiriX in laparoscopic and robotic surgery: not only a matter of fashion. J Hepatobiliary Pancreat Sci (2011) 1.16
The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases. Cancer (2012) 1.16
'Liver first' approach in the treatment of colorectal cancer with synchronous liver metastases. Dig Surg (2009) 1.16
Segmental duodenectomy for gastrointestinal stromal tumor of the duodenum. World J Gastroenterol (2010) 1.14
Surgical management of patients with synchronous colorectal liver metastasis: a multicenter international analysis. J Am Coll Surg (2013) 1.14
Long term results after complete or incomplete surgical resection of liver hydatid disease. Swiss Med Wkly (2003) 1.14
Positron-emission tomography imaging of early events after transplantation of islets of Langerhans. Transplantation (2005) 1.14
IgG4-associated cholangitis: a comparative histological and immunophenotypic study with primary sclerosing cholangitis on liver biopsy material. Mod Pathol (2009) 1.11
A nomogram to predict long-term survival after resection for intrahepatic cholangiocarcinoma: an Eastern and Western experience. JAMA Surg (2014) 1.11
Transumbilical single-incision laparoscopic intracorporeal anastomosis for gastrojejunostomy: case report. Surg Endosc (2009) 1.11
Lymphatic vessel density and vascular endothelial growth factor-C expression correlate with malignant behavior in human pancreatic endocrine tumors. Clin Cancer Res (2004) 1.10
Are there any prognostic factors for small intestinal stromal tumors? Am J Surg (2004) 1.09
Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: living versus deceased donor transplantation. Hepatology (2011) 1.08
A model for dropout assessment of candidates with or without hepatocellular carcinoma on a common liver transplant waiting list. Hepatology (2012) 1.08
Acute vascular rejection of xenografts: roles of natural and elicited xenoreactive antibodies in activation of vascular endothelial cells and induction of procoagulant activity. Transplantation (2004) 1.07
Fibrogenic potential of human multipotent mesenchymal stromal cells in injured liver. PLoS One (2009) 1.07
Management of hepatocellular adenoma: solitary-uncomplicated, multiple and ruptured tumors. World J Gastroenterol (2005) 1.06
Immunosuppressive effects of streptozotocin-induced diabetes result in absolute lymphopenia and a relative increase of T regulatory cells. Diabetes (2011) 1.05
Proximal location of colon cancer is a risk factor for development of metachronous colorectal cancer: a population-based study. Dis Colon Rectum (2005) 1.05
Surgical management of early-stage hepatocellular carcinoma: resection or transplantation? J Gastrointest Surg (2008) 1.04
Assessment of quality of life in patients with rectal cancer treated by preoperative radiotherapy: a longitudinal prospective study. Int J Radiat Oncol Biol Phys (2005) 1.04
Expansion and tissue infiltration of an allospecific CD4+CD25+CD45RO+IL-7Ralphahigh cell population in solid organ transplant recipients. J Exp Med (2007) 1.04
Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab. Transpl Int (2007) 1.04
Severe acute pancreatitis and reduced acinar cell apoptosis in the exocrine pancreas of mice deficient for the Cx32 gene. Gastroenterology (2003) 1.04
Neoadjuvant radiochemotherapy for locally advanced gastric cancer: long-term results of a phase I trial. Int J Radiat Oncol Biol Phys (2005) 1.03
Neoadjuvant chemotherapy in patients with stage IV colorectal cancer: a comparison of histological response in liver metastases, primary tumors, and regional lymph nodes. Ann Surg Oncol (2010) 1.03
Minimally invasive necrosectomy for infected necrotizing pancreatitis. Pancreas (2008) 1.03
A Prospective longitudinal evaluation of quality of life after abdominoperineal resection. J Surg Oncol (2008) 1.02